Pill vs. surgery: new hope for carpal tunnel sufferers
NCT ID NCT06294821
Summary
This study is testing whether an existing FDA-approved drug called 4-aminopyridine can effectively treat carpal tunnel syndrome or delay the need for surgery. Researchers will enroll 160 adults with confirmed carpal tunnel who would otherwise undergo surgery. Participants will take the drug twice daily for 6 weeks while researchers track symptom improvement and nerve function over 56 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPRESSION NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.